Altered epigenetic signals in human disease

19Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The genetic information of almost all eukaryotic cells is stored in chromatin. In cancer cells, alterations in chromatin organization or in its epigenetic marks occur frequently. Among these are changes in the patterns of DNA and histone methylation. Using Acute Promyelocytic Leukemia as model system we could demonstrate a direct correlation of epigenetic events induced by the driving oncogene product PML-RARα and cancer progression. Several of the enzymes ultimately responsible for these events can be inhibited by small compound inhibitors and thus can serve as targets in cancer therapy. In this article, we review the role of DNA methylation, histone methylation and chromatin alterations in human diseases. A picture is emerging in which these epigenetic signals "cross-talk" and are implicated in the physiological and pathological spreading of gene silencing. ©2004 Landes Bioscience.

Cite

CITATION STYLE

APA

Di Croce, L., Buschbeck, M., Gutierrez, A., Joval, I., Morey, L., Villa, R., & Minucci, S. (2004). Altered epigenetic signals in human disease. Cancer Biology and Therapy. Landes Bioscience. https://doi.org/10.4161/cbt.3.9.1103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free